BioInvent International AB Asset Resilience Ratio

Latest as of June 2025: 42.92%

BioInvent International AB asset resilience ratio. BioInvent International AB (BINV) has an Asset Resilience Ratio of 42.92% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read BINV total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

Skr393.47 Million

≈ $42.34 Million USD Cash + Short-term Investments

Total Assets

Skr916.67 Million

≈ $98.65 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of BioInvent International AB (2000–2024)

Asset resilience ratio of BioInvent International AB from 2000 to 2024. This chart shows how BioInvent International AB's Asset Resilience Ratio has changed over time. See cash generation quality of BioInvent International AB to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down BioInvent International AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BINV asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr393.47 Million	42.92%
Total Liquid Assets	Skr393.47 Million	42.92%

Asset Resilience Insights

Very High Liquidity: BioInvent International AB maintains exceptional liquid asset reserves at 42.92% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

BioInvent International AB Industry Peers by Asset Resilience Ratio

Compare BioInvent International AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

BioInvent International AB Asset Resilience Ratio by Year (2000–2024)

BioInvent International AB asset resilience ratio by year from 2000 to 2024. The table below shows the annual Asset Resilience Ratio data for BioInvent International AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	43.70%	Skr432.33 Million ≈ $46.53 Million	Skr989.24 Million ≈ $106.46 Million	-14.09pp
2023-12-31	57.79%	Skr809.15 Million ≈ $87.08 Million	Skr1.40 Billion ≈ $150.68 Million	+28.44pp
2022-12-31	29.34%	Skr502.43 Million ≈ $54.07 Million	Skr1.71 Billion ≈ $184.26 Million	+17.45pp
2021-12-31	11.89%	Skr172.07 Million ≈ $18.52 Million	Skr1.45 Billion ≈ $155.75 Million	-5.79pp
2017-12-31	17.68%	Skr30.06 Million ≈ $3.23 Million	Skr170.05 Million ≈ $18.30 Million	-32.29pp
2014-12-31	49.97%	Skr37.03 Million ≈ $3.98 Million	Skr74.11 Million ≈ $7.98 Million	-11.52pp
2013-12-31	61.49%	Skr50.07 Million ≈ $5.39 Million	Skr81.44 Million ≈ $8.76 Million	-6.59pp
2012-12-31	68.07%	Skr79.34 Million ≈ $8.54 Million	Skr116.54 Million ≈ $12.54 Million	+28.41pp
2011-12-31	39.67%	Skr81.62 Million ≈ $8.78 Million	Skr205.76 Million ≈ $22.14 Million	-10.41pp
2010-12-31	50.07%	Skr69.12 Million ≈ $7.44 Million	Skr138.03 Million ≈ $14.85 Million	+42.17pp
2009-12-31	7.91%	Skr9.98 Million ≈ $1.07 Million	Skr126.25 Million ≈ $13.59 Million	-46.65pp
2008-12-31	54.56%	Skr161.18 Million ≈ $17.35 Million	Skr295.43 Million ≈ $31.79 Million	-2.40pp
2007-12-31	56.96%	Skr154.37 Million ≈ $16.61 Million	Skr271.00 Million ≈ $29.16 Million	+43.51pp
2006-12-31	13.45%	Skr19.96 Million ≈ $2.15 Million	Skr148.33 Million ≈ $15.96 Million	-8.99pp
2005-12-31	22.45%	Skr59.78 Million ≈ $6.43 Million	Skr266.34 Million ≈ $28.66 Million	+17.18pp
2000-12-31	5.27%	Skr10.23 Million ≈ $1.10 Million	Skr194.26 Million ≈ $20.91 Million	--

pp = percentage points

About BioInvent International AB

ST:BINV Sweden Biotechnology

Market Cap

$38.45 Million

Skr357.32 Million SEK

Market Cap Rank

#22679 Global

#426 in Sweden

Share Price

Skr5.43

Change (1 day)

-4.90%

52-Week Range

Skr5.43 - Skr33.90

All Time High

Skr95.26